IL11RA and non-small cell lung carcinoma: MLC1 enhances the sensitivity of cells to apoptosis, improving the effectiveness of NSCLC treatment (83).IL11RA, located on chromosome 9, initiates signaling pathways that affect cell growth, proliferation, and differentiation.